HopeStage
Back to all studies
UnknownNCT04071600

Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder

Medication studyAges 18–65United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Valhalla and 1 more locationSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: November 1, 2019
Recruitment status
Unknown
Enrollment listed in the registry
117
Sponsor
New York Medical College
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT04071600
Official title
Show the full official title

Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder (ASD)

Recruitment & locations

Status unknown

Valhalla

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York Medical College, a university.

Does this study involve medication?

Yes. The study involves medication, including Neuropeptide Y.

Who can participate?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies